MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    a-synuclein neurotoxicity and spreading using Lewy Body extracts from Parkinson Disease Brains: In vitro screening by cell-based assays

    E. Bezard, F. Cavaliere, L. Cerf, B. Dehay, P. Ramos-Gonzalez, F. De Giorgi, M. Bourdenx, A. Bessede, J. Obeso, F. Ichas, C. Matute (Bordeaux, France)

    Objective: To define the kinetics of neuronal and astrocytic abnormalities induced by human-derived α-syn aggregates for grounding the use of such system to identify and…
  • 2017 International Congress

    Anti-synuclein alpha antibodies and IL-1β at Parkinson Disease (PD).

    A. Boika, V. Ponomarev, H. Ivanchik (Minsk, Belarus)

    Objective: Determine a correlation between the levels of anti-synuclein alpha antibodies and IL-1β at serum and CSF of patients with PD. Background: PD is a…
  • 2017 International Congress

    Admixing augments nigral dopaminergic correlates during development to impart resistance to MPTP-toxicity at adulthood

    V. D J, Y. H, R. T R, P. Anand Alladi (Bangalore, India)

    Objective: Establish the developmental basis for varying nigral dopaminergic (DA) correlates in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) susceptible C57BL/6, MPTP resistant CD-1 and their resistant crossbred mice. Background:…
  • 2017 International Congress

    Dopamine substitution restores effective connectivity between prefrontal and premotor areas in Parkinson’s disease

    P. Loehrer, F. Nettersheim, F. Jung, I. Weber, C. Huber, T. Dembek, E. Pelzer, M. Tittgemeyer, L. Timmermann (Marburg, Germany)

    Objective: To assess influences of dopamine deficiency on the causal interplay within the motor network during bimanual finger tapping in Parkinson's disease (PD) patients. Background:…
  • 2017 International Congress

    Assessment of neurodegeneration and spreading of α-synuclein pathology induced by structurally defined α-synuclein assemblies in wild-type mice

    E. Bezard, M. Bourdenx, L. Arcuri, L. Bousset, R. Melki, B. Dehay (Bordeaux, France)

    Objective: The aim of this study was to investigate, in wild-type mice, the spreading and neurodegeneration induced by intracerebral injection of structurally well-defined α-synuclein assemblies…
  • 2017 International Congress

    Serum lipid profile in Parkinsons disease patients from Southern Spain

    C. Mendez Barrio, D. Macias Garcia, S. Jesus, M.A. Labrador Espinosa, L. Vargas Gonzalez, M. Bernal Escudero, A. Adarmes Gomez, F. Carrillo Garcia, M. Carvallo Cordero, P. Gomez Garr, P. Mir (Seville, Spain)

    Objective: Our first aim was to evaluate differences in the blood lipid profile levels between Parkinsons disease (PD) patients and healthy controls (HC). Secondly, in…
  • 2017 International Congress

    Expression of late cell cycle markers in Parkinson Disease and Lewy Body Dementia

    I. Martinez-Valbuena, R. Valenti-Azcarate, M.M. Carmona-Abellan, I. Marcilla-Garcia, I. Gaston-Zubimendi, G. Marti-Andres, M.-T. Tuñon-Alvarez, M.-R. Luquin-Piudo (Pamplona, Spain)

    Objective: The objective of this study is to determine the expression of late cell cycle markers in Parkinson Disease (PD) and Lewy Body Dementia (LBD) Background:…
  • 2017 International Congress

    Premovement betaband event-related desynchronization related to simple lower limb movement and simulated gait initiation in Parkinson’s disease patients: MEG study

    J.Y. Yun, J.S. Kim, H.W. Lee (Seoul, Republic of Korea)

    Objective: To compare premovement event related desynchronization (ERD) between simple lower limb movement and simulated gait initiation in Parkinson’s disease (PD) patients using Magnetoencephalography (MEG).…
  • 2017 International Congress

    Antibody binding differences in alpha-synuclein from Parkinson’s disease and multiple system atrophy

    T. Yamasaki, A. Welleford (Lexington, KY, USA)

    Objective: Determine whether alpha-synuclein derived from Parkinson's disease (PD) and multiple system atrophy (MSA) brains has different conformations as defined by biochemical and antibody-based approaches. Background: There…
  • 2017 International Congress

    Development of nano-formulation containing crocetin for the protective and beneficial effect against 6-hydroxydopamine induced Parkinson’s disease model via altered the genetic backgrounds

    V. Kumar, A. Verma, P. Bhatt (Allahabad, India)

    Objective: Parkinson’s disease (PD) induced by the interaction between the number of factors viz., aging, genetics toxins, mitochondrial deformity and oxidative stress. Various evidences suggest…
  • « Previous Page
  • 1
  • …
  • 1249
  • 1250
  • 1251
  • 1252
  • 1253
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley